Recipharm in Zwickau

Located in central Germany near Dresden, Recipharm’s Zwickau facility is a key European hub for oral solid dose (OSD) development and manufacturing. The site combines advanced processing technologies with Recipharm’s global CDMO expertise to support pilot‑scale through full commercial production of tablets, capsules, coated multiparticulates and complex OSD formulations.

Site capabilities

Core expertise

• Bulk OSD manufacturing of tablets, granules, pellets and capsules
• Granulation, compression, encapsulation, coating and pelletisation technology
• Licensed to manufacture controlled substances (schedule 5 up to 2)
• ReciPredict™ technology for accelerated formulation development and smoother tech transfer

Integrated services across Recipharm network

The Zwickau site works in close collaboration with Recipharm’s global services to support the full product lifecycle, including:

• ReciPredict™ data driven development
• Oral solid dose manufacturing
• Controlled substance handling and production
• Technology transfer
• Drug product development
• Analytical services

Quality, compliance & regulatory readiness

Global regulatory approvals

• Local German Authority (EU GMP)
• U.S. FDA
• ANVISA (Brazil)
• PMDA (Japan)
• Russian and Turkish authorities

Certified management systems

The site operates with the following ISO aligned quality systems

• ISO 14001 - Environmental management
• ISO 50001 - Energy management
• ISO 45001 - OH&S

Sustainability commitment

• EcoVadis Gold rating, recognising Recipharm’s strong ESG performance and commitment to responsible manufacturing
• 100% electricity from renewable sources

Careers at Recipharm Zwickau

Explore career opportunities at Recipharm’s Zwickau facility and join a global CDMO network dedicated to advancing high‑quality oral solid dose medicines.

Explore current career opportunities at Recipharm